Loading...
PhD Janja Zupan

PhD Janja Zupan
no.: 32306 source: ARIS

researcher – active in research organisation
  janja.zupanat signffa.uni-lj.si
Research activity

Code Science Field Subfield
3.07.00  Medical sciences  Metabolic and hormonal disorders   
1.09.00  Natural sciences and mathematics  Pharmacy   

Code Science Field
B580  Biomedical sciences  Skeleton, muscle system, rheumatology locomotion 
Bibliography Representative bibliographic units | Personal | COBISS+
source: COBISS
source: SICRIS
Points
429.69
A''
0
A'
86.07
A1/2
278.55
CI10
861
CImax
156
h10
15
A1
1.4
A3
0.17
Data for the last 5 years (citations for the last 10 years) on September 30, 2026; Data for score A3 calculation refer to period 2021-2025 (2022, 2025)
Data for ARIS tenders ( 21.05.2024 – Target research programmes, archive )
Database Linked records Citations Pure citations Average pure citations
WoS 47  869  788  16.77 
Scopus 47  1,022  928  19.74 
Education
source: ARIS
Level of education Professional title Study subject Faculty Year
  B. Sc.     SI University of Ljubljana, Faculty of Pharmacy 2005 
Doctoral degree  Ph. D.   Clinical biochemistry  SI University of Ljubljana, Faculty of Pharmacy 2012 
Doctoral dissertations and other final papers Show
Obtaining results now
source: COBISS
Employments
source: ARIS
Type of employment Research org. Research group Date of employment Position Role Title
Full time employment (120%, RD:20%)  University of Ljubljana, Faculty of Pharmacy  Chair for Pharmaceutical Chemistry  11/1/2009  Assistant  Researcher  Associate professor 
Research projects Legend
source: ARIS
no. Code Title Period Head of the Last Period No. of publications
1. J3-70142  Charting new horizons: Unlocking the potential of NOD1, a versatile force in immunity   3/1/2026 - 2/28/2029  PhD Žiga Jakopin   882 
2. BI-JP/25-27-004  Synovial stem cells as treatment tools for degenerative joint diseases and injuries   4/1/2025 - 3/31/2027  PhD Janja Zupan   166 
3. J3-50116  Matters of the heart: elucidating the cardiotoxic mechanism of proteasome inhibitors   10/1/2023 - 9/30/2026  PhD Martina Gobec   2,582 
4. J3-4496  Next-generation adjuvants for mucosal vaccines   10/1/2022 - 9/30/2026  PhD Žiga Jakopin   1,606 
5. J3-3062  Autologous immunohybridomas and advanced treatment of stage II and III triple-negative breast cancer   10/1/2021 - 9/30/2025  PhD Matjaž Jeras   2,881 
6. L3-3176  The Role and Potential Application of Immunomodulatory Mesenchymal Stem Cells in COVID- 19 Disease   10/1/2021 - 9/30/2024  PhD Janja Zupan   3,838 
7. J7-2603  EFFICACY OF BACTERIOPHAGES FOR TREATEMENT OF EXTRACELULAR AND INTRACELULAR BACTERIAL INFECTIONS OF IMPLANTANTS   9/1/2020 - 8/31/2023  PhD Aleš Podgornik   2,593 
8. J3-1749  Mesenchymal stem cells-the keepers of tissue endogenous regenerative capacity facing up to aging of the musculoskeletal system   7/1/2019 - 6/30/2023  PhD Janja Zupan   2,696 
9. J3-1759  Comprehensive characterization of GWAS hits – pipeline to novel drug targets for anabolic treatment of osteoporosis (GWASforAna)   7/1/2019 - 6/30/2022  PhD Janja Marc   5,555 
10. J3-4313  Vpliv aktivnega transporta imatiniba in različnih genotipov pacientov na uspešnost terapije kronične mieloične levkemije (Slovene)   7/1/2011 - 6/30/2014  PhD Albin Kristl   3,435 
11. J3-2330  Genetski dejavniki pri osteoporozi (Slovene)   5/1/2009 - 4/30/2012  PhD Janja Marc   2,591 
ARIS research and infrastructure programmes Legend
source: ARIS
no. Code Title Period Head of the Last Period No. of publications
1. P1-0420  Advanced immunological drugs and cell-based approaches in pharmacy   1/1/2022 - 12/31/2027 PhD Žiga Jakopin   1,723 
2. P3-0298  Genes, hormones and personality changes in metabolic disorders   1/1/2019 - 12/31/2027 PhD Andrej Janež   4,143 
3. P3-0298  Genes, hormones and personality changes in metabolic disorders   1/1/2015 - 12/31/2018 PhD Andrej Janež   5,432 
4. P3-0298  Genes, hormones and personality changes in metabolic disorders   1/1/2009 - 12/31/2014 PhD Janez Preželj   5,137 
Views history
Favourite